Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

493
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493
Cancer Vaccines01:30

Cancer Vaccines

347
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
347
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Cancer Therapies02:49

Cancer Therapies

7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

16.7K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.7K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

An extracellular, optogenetic antibody platform for stimulus-gated antigen recognition and modulation of cell behavior.

Cell chemical biology·2026
Same author

Transcription Factor Pet-1/FEV as a Potential Therapeutic Target in Anxiety and Depressive Disorders.

CNS & neurological disorders drug targets·2026
Same author

Durumamide A Inhibits NLRP3 Assembly, Limiting Pro-Inflammatory Signaling in Human Gingival Fibroblasts.

Journal of periodontal research·2026
Same author

Unlocking IL-33: New Insights into Tumor Immunity.

Immune network·2025
Same author

Therapeutic potential of polysaccharides in inflammation: current insights and future directions.

International immunopharmacology·2025
Same author

Surfactant-free synthesis of gold nanoparticle-decorated poly(<i>o</i>-phenylenediamine) sub-microspheres as surface-confined signaling probes for label-free electrochemical immunosensing of <i>E. coli O157:H7</i>.

Journal of materials chemistry. B·2025

相关实验视频

Updated: Jun 14, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

9.4K

工程干扰素用于癌症免疫治疗.

Juhee Lim1, Heung Kyu Lee2

  • 1Laboratory of Host Defenses, Department of Biological Sciences, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Republic of Korea; Graduate School of Medical Science and Engineering, KAIST, Daejeon 34141, Republic of Korea.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
|September 7, 2024
PubMed
概括
此摘要是机器生成的。

干扰素 (IFN) 疗法在癌症治疗方面表现有前途. 细胞因子工程增强了I型和III型IFN向瘤的输送,但安全临床使用仍然存在挑战.

关键词:
细胞因子工程是指细胞因子的工程.免疫治疗是一种免疫疗法.基于干扰素的治疗方法瘤微环境是一个微环境.一类干扰子I型干扰子第三种类型的干扰素.

更多相关视频

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
10:00

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

Published on: March 24, 2015

13.3K
Experimental Infection with Listeria monocytogenes as a Model for Studying Host Interferon-&#947; Responses
10:10

Experimental Infection with Listeria monocytogenes as a Model for Studying Host Interferon-γ Responses

Published on: November 16, 2016

13.6K

相关实验视频

Last Updated: Jun 14, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

9.4K
High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
10:00

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

Published on: March 24, 2015

13.3K
Experimental Infection with Listeria monocytogenes as a Model for Studying Host Interferon-&#947; Responses
10:10

Experimental Infection with Listeria monocytogenes as a Model for Studying Host Interferon-γ Responses

Published on: November 16, 2016

13.6K

科学领域:

  • 免疫学 免疫学 免疫学
  • 在瘤学瘤学.
  • 生物技术是生物技术.

背景情况:

  • 干扰素 (IFN) 是免疫力至关重要的细胞因子.
  • I型IFN具有广泛的影响,并被用于癌症治疗.
  • 第三种类型的IFN提供了针对性癌症治疗的潜力,副作用较少.

研究的目的:

  • 审查基于IFN的癌症治疗药物的发展.
  • 为突出IFN传递细胞因子工程的进步.
  • 为了确定IFN疗法临床应用的剩余障碍.

主要方法:

  • 对癌症I型和III型IFN现有文献的综述.
  • 分析针对性传递的细胞因子工程策略.
  • 讨论临床挑战和未来的方向.

主要成果:

  • 针对各种瘤,正在开发基于IFN的疗法.
  • 细胞因子工程使得IFN能够更好地传递到瘤部位.
  • 由于特定的受体表达,III型IFN呈现出潜在的更安全的替代方案.

结论:

  • 基于IFN的癌症疗法正在通过细胞因子工程取得进展.
  • 需要进一步的研究,以克服临床整合的毒性和疗效挑战.
  • 第三种类型的IFN可能为癌症免疫疗法提供了更有针对性的方法.